Cargando…

Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape

Spinal muscular atrophy (SMA) is a rare autosomal recessive neuromuscular disease that is characterized by progressive muscle atrophy (degeneration), including skeletal muscles in charge of the ability to move. SMA is caused by defects in the SMN1 gene (Survival of Motor Neuron 1) which encodes a pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponomarev, Aleksei S., Chulpanova, Daria S., Yanygina, Lina M., Solovyeva, Valeriya V., Rizvanov, Albert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530942/ https://www.ncbi.nlm.nih.gov/pubmed/37762045 http://dx.doi.org/10.3390/ijms241813743

Ejemplares similares

Comparative Analysis of Natural and Cytochalasin B-Induced Membrane Vesicles from Tumor Cells and Mesenchymal Stem Cells
por: Gilazieva, Zarema, et al.
Publicado: (2022)

Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis
por: Chulpanova, Daria S., et al.
Publicado: (2022)

The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity
por: Chulpanova, Daria S., et al.
Publicado: (2022)

The Dual Role of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Carcinogenesis
por: Gilazieva, Zarema, et al.
Publicado: (2022)

Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells
por: Chulpanova, Daria S., et al.
Publicado: (2022)

Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine
por: Gilazieva, Zarema, et al.
Publicado: (2020)

Therapeutic Prospects of Extracellular Vesicles in Cancer Treatment
por: Chulpanova, Daria S., et al.
Publicado: (2018)

Mouse Tumor Models for Advanced Cancer Immunotherapy
por: Chulpanova, Daria S., et al.
Publicado: (2020)

Eighteen Years with Spinal Muscular Atrophy (SMA) Type 1
por: Valencia, Borja, et al.
Publicado: (2013)

Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada
por: McMillan, H.J., et al.
Publicado: (2021)

Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA Cohort
por: Jones, Cynthia C., et al.
Publicado: (2020)

Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy
por: Chulpanova, Daria S., et al.
Publicado: (2020)

Functionality of a bicistronic construction containing HEXA and HEXB genes encoding β-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses
por: Shaimardanova, Alisa A., et al.
Publicado: (2021)

SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy
por: Kobayashi, Dione T., et al.
Publicado: (2013)

Measuring Fatigue and Fatigability in Spinal Muscular Atrophy (SMA): Challenges and Opportunities
por: Rodriguez-Torres, Rafael S., et al.
Publicado: (2023)

Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment
por: Chulpanova, Daria S., et al.
Publicado: (2018)

New Approaches to Tay-Sachs Disease Therapy
por: Solovyeva, Valeriya V., et al.
Publicado: (2018)

Extracellular vesicles in the diagnosis and treatment of central nervous system diseases
por: Shaimardanova, Alisa A., et al.
Publicado: (2019)

Analysis of the Interaction of Human Neuroblastoma Cell-Derived Cytochalasin B Induced Membrane Vesicles with Mesenchymal Stem Cells Using Imaging Flow Cytometry
por: Solovyeva, Valeriya V., et al.
Publicado: (2022)

Safety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs
por: Mullagulova, Aysilu, et al.
Publicado: (2023)

A call to introduce newborn screening for spinal muscular atrophy (SMA) in Scotland
por: Gillingwater, Thomas H., et al.
Publicado: (2022)

Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
por: Paracha, Noman, et al.
Publicado: (2021)

Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression
por: Ponomarev, Alexey, et al.
Publicado: (2022)

Recombinant Viruses for Cancer Therapy
por: Chulpanova, Daria S., et al.
Publicado: (2018)

Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen
por: Wurster, Claudia D., et al.
Publicado: (2019)

Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)
por: Zanetta, Chiara, et al.
Publicado: (2014)

Spontaneous Breathing Pattern as Respiratory Functional Outcome in Children with Spinal Muscular Atrophy (SMA)
por: LoMauro, A., et al.
Publicado: (2016)

Therapeutic decisions under uncertainty for spinal muscular atrophy: The DECISIONS-SMA study protocol
por: Saposnik, Gustavo, et al.
Publicado: (2022)

Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
por: Paracha, Noman, et al.
Publicado: (2022)

Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA)
por: Mix, Lucas, et al.
Publicado: (2021)

Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches
por: Shaimardanova, Alisa A., et al.
Publicado: (2020)

Gene and Cell Therapy for Epilepsy: A Mini Review
por: Shaimardanova, Alisa A., et al.
Publicado: (2022)

Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
por: Issa, Shaza S., et al.
Publicado: (2023)

Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study
por: Finkel, Richard S., et al.
Publicado: (2012)

Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse
por: McGovern, Vicki L., et al.
Publicado: (2015)

Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls
por: Czech, Christian, et al.
Publicado: (2015)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
por: Hensel, Niko, et al.
Publicado: (2020)

Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment
por: Monnette, Alisha, et al.
Publicado: (2021)

Drug Discovery of Spinal Muscular Atrophy (SMA) from the Computational Perspective: A Comprehensive Review
por: Chong, Li Chuin, et al.
Publicado: (2021)

Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers
por: Sutherland, C. Simone, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5sp5mkrkklju8u9chsricjjde